On July 29, Procter & Gamble declined 5.15% in regular trading, trading at $143.17/share, with turnover of $304 million. The sell-off was triggered by the company's Q4 FY2026 earnings release before market open.

Procter & Gamble reported net sales of $21.2 billion, missing the consensus estimate of $21.34 billion. Organic revenue growth came in flat at 0%, significantly below the expected 1.85%. Core EPS of $1.43 slightly beat the $1.41 estimate but declined 3.38% year-over-year from $1.48. The CFO highlighted that U.S. trade dynamics and surging input costs pressured results.

More critically, the FY2027 outlook disappointed investors. The CFO cited approximately $1 billion in after-tax profit headwinds from rising oil prices and elevated raw material, energy, and transportation costs, calling this the single largest variable in guidance. Persistent inflation continues driving consumers toward cheaper alternatives, further weakening demand for the company's brands. Additionally, CEO Shailesh Jejurikar will assume the Chairman role effective August 1, following Jon Moeller's retirement after nearly four decades at the company.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)